AU2001261116A1 - Method and compositions for drug discovery - Google Patents

Method and compositions for drug discovery

Info

Publication number
AU2001261116A1
AU2001261116A1 AU2001261116A AU6111601A AU2001261116A1 AU 2001261116 A1 AU2001261116 A1 AU 2001261116A1 AU 2001261116 A AU2001261116 A AU 2001261116A AU 6111601 A AU6111601 A AU 6111601A AU 2001261116 A1 AU2001261116 A1 AU 2001261116A1
Authority
AU
Australia
Prior art keywords
compositions
drug discovery
discovery
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261116A
Inventor
Charles Pidgeon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001261116A1 publication Critical patent/AU2001261116A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2600/00—Assays involving molecular imprinted polymers/polymers created around a molecular template
AU2001261116A 2000-05-03 2001-05-02 Method and compositions for drug discovery Abandoned AU2001261116A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20154500P 2000-05-03 2000-05-03
US60201545 2000-05-03
US61162600A 2000-07-07 2000-07-07
US09611626 2000-07-07
PCT/US2001/014091 WO2001084154A1 (en) 2000-05-03 2001-05-02 Method and compositions for drug discovery

Publications (1)

Publication Number Publication Date
AU2001261116A1 true AU2001261116A1 (en) 2001-11-12

Family

ID=26896848

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261116A Abandoned AU2001261116A1 (en) 2000-05-03 2001-05-02 Method and compositions for drug discovery

Country Status (3)

Country Link
AU (1) AU2001261116A1 (en)
CA (1) CA2407889A1 (en)
WO (1) WO2001084154A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002230788A1 (en) 2000-12-11 2002-06-24 Hk Pharmaceuticals, Inc. Multiplexed protein expression and activity assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053492A (en) * 1986-08-07 1991-10-01 Board Of Regents, The University Of Texas System Immunopurification using monoclonal antibodies to Mojave toxin
US5961923A (en) * 1995-04-25 1999-10-05 Irori Matrices with memories and uses thereof
US6150501A (en) * 1998-02-24 2000-11-21 New England Biolabs, Inc. Tyrosine-containing cyclophilin and related methods

Also Published As

Publication number Publication date
CA2407889A1 (en) 2001-11-08
WO2001084154A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU781269C (en) Pharmaceutical compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU7490200A (en) New and improved formulation for paclitaxel
AU2001274307A1 (en) Pharmaceutical compositions
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001280599A1 (en) Compounds and methods
AU5326100A (en) Pharmaceutical compositions and methods for use
AU2001253418A1 (en) Compounds and methods
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001279850A1 (en) Method and arrangement for studsystem
AU2001243394A1 (en) Compounds and methods
AU2001273919A1 (en) Pharmaceutical compositions
AU2002224938A1 (en) Compounds that affect CD83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
AU2001233932A1 (en) Method and composition
AUPQ872300A0 (en) Compounds and methods
AU4085201A (en) Pharmaceutical composition
AU2001278951A1 (en) Compounds and methods
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU2002246659A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2002239775A1 (en) Chemical-library composition and method
AU2002246658A1 (en) Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
AU2001259564A1 (en) Pharmaceutical compositions and methods for use
AU2002235277A1 (en) Compounds and methods